Although historical AFP levels are still prevalent in the literature (> 100 ng/mL [5] and > 400 ng/mL [6]), their ability to assess prognosis in the current landscape of early-stage HCC is limited. The gene discussed is AFP; the disease is hepatocellular carcinoma.